These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 31808923

  • 1. Assessment of the Diagnostic Utility of Serum MicroRNA Classification in Patients With Diffuse Glioma.
    Ohno M, Matsuzaki J, Kawauchi J, Aoki Y, Miura J, Takizawa S, Kato K, Sakamoto H, Matsushita Y, Takahashi M, Miyakita Y, Ichimura K, Narita Y, Ochiya T.
    JAMA Netw Open; 2019 Dec 02; 2(12):e1916953. PubMed ID: 31808923
    [Abstract] [Full Text] [Related]

  • 2. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
    Yue X, Lan F, Hu M, Pan Q, Wang Q, Wang J.
    J Neurosurg; 2016 Jan 02; 124(1):122-8. PubMed ID: 26230475
    [Abstract] [Full Text] [Related]

  • 3. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
    Regazzo G, Terrenato I, Spagnuolo M, Carosi M, Cognetti G, Cicchillitti L, Sperati F, Villani V, Carapella C, Piaggio G, Pelosi A, Rizzo MG.
    J Exp Clin Cancer Res; 2016 Jul 30; 35(1):124. PubMed ID: 27476114
    [Abstract] [Full Text] [Related]

  • 4. Development and Validation of an Esophageal Squamous Cell Carcinoma Detection Model by Large-Scale MicroRNA Profiling.
    Sudo K, Kato K, Matsuzaki J, Boku N, Abe S, Saito Y, Daiko H, Takizawa S, Aoki Y, Sakamoto H, Niida S, Takeshita F, Fukuda T, Ochiya T.
    JAMA Netw Open; 2019 May 03; 2(5):e194573. PubMed ID: 31125107
    [Abstract] [Full Text] [Related]

  • 5. Serum miR-21 is a diagnostic and prognostic marker of primary central nervous system lymphoma.
    Mao X, Sun Y, Tang J.
    Neurol Sci; 2014 Feb 03; 35(2):233-8. PubMed ID: 23832112
    [Abstract] [Full Text] [Related]

  • 6. Glioblastoma and primary central nervous system lymphoma: Preoperative differentiation by using MRI-based 3D texture analysis.
    Xiao DD, Yan PF, Wang YX, Osman MS, Zhao HY.
    Clin Neurol Neurosurg; 2018 Oct 03; 173():84-90. PubMed ID: 30092408
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA biomarkers in whole blood for detection of pancreatic cancer.
    Schultz NA, Dehlendorff C, Jensen BV, Bjerregaard JK, Nielsen KR, Bojesen SE, Calatayud D, Nielsen SE, Yilmaz M, Holländer NH, Andersen KK, Johansen JS.
    JAMA; 2018 Oct 03; 311(4):392-404. PubMed ID: 24449318
    [Abstract] [Full Text] [Related]

  • 8. MicroRNA-30c as a novel diagnostic biomarker for primary and secondary B-cell lymphoma of the CNS.
    Baraniskin A, Chomiak M, Ahle G, Gress T, Buchholz M, Turewicz M, Eisenacher M, Margold M, Schlegel U, Schmiegel W, Hahn S, Schroers R.
    J Neurooncol; 2018 May 03; 137(3):463-468. PubMed ID: 29327175
    [Abstract] [Full Text] [Related]

  • 9. MR imaging based fractal analysis for differentiating primary CNS lymphoma and glioblastoma.
    Liu S, Fan X, Zhang C, Wang Z, Li S, Wang Y, Qiu X, Jiang T.
    Eur Radiol; 2019 Mar 03; 29(3):1348-1354. PubMed ID: 30167811
    [Abstract] [Full Text] [Related]

  • 10. Machine learning applications for the differentiation of primary central nervous system lymphoma from glioblastoma on imaging: a systematic review and meta-analysis.
    Nguyen AV, Blears EE, Ross E, Lall RR, Ortega-Barnett J.
    Neurosurg Focus; 2018 Nov 01; 45(5):E5. PubMed ID: 30453459
    [Abstract] [Full Text] [Related]

  • 11. Serum expression level of miR-504 can differentiate between glioblastoma multiforme and solitary brain metastasis of non-small cell lung carcinoma.
    Jin Z, Jin RH, Ma C, Li HS, Xu HY.
    J BUON; 2017 Nov 01; 22(2):474-480. PubMed ID: 28534372
    [Abstract] [Full Text] [Related]

  • 12. High-Throughput Sequencing-Based Identification of Serum Exosomal Differential miRNAs in High-Grade Glioma and Intracranial Lymphoma.
    Wang S, Xu Z, Zhang C, Yu R, Jiang J, Wang C, Qu C.
    Biomed Res Int; 2020 Nov 01; 2020():2102645. PubMed ID: 33083454
    [Abstract] [Full Text] [Related]

  • 13. Diffusion radiomics as a diagnostic model for atypical manifestation of primary central nervous system lymphoma: development and multicenter external validation.
    Kang D, Park JE, Kim YH, Kim JH, Oh JY, Kim J, Kim Y, Kim ST, Kim HS.
    Neuro Oncol; 2018 Aug 02; 20(9):1251-1261. PubMed ID: 29438500
    [Abstract] [Full Text] [Related]

  • 14. Differentiation between primary CNS lymphoma and glioblastoma: qualitative and quantitative analysis using arterial spin labeling MR imaging.
    You SH, Yun TJ, Choi HJ, Yoo RE, Kang KM, Choi SH, Kim JH, Sohn CH.
    Eur Radiol; 2018 Sep 02; 28(9):3801-3810. PubMed ID: 29619520
    [Abstract] [Full Text] [Related]

  • 15. CSF neopterin level as a diagnostic marker in primary central nervous system lymphoma.
    Viaccoz A, Ducray F, Tholance Y, Barcelos GK, Thomas-Maisonneuve L, Ghesquières H, Meyronet D, Quadrio I, Cartalat-Carel S, Louis-Tisserand G, Jouanneau E, Guyotat J, Honnorat J, Perret-Liaudet A.
    Neuro Oncol; 2015 Nov 02; 17(11):1497-503. PubMed ID: 26014047
    [Abstract] [Full Text] [Related]

  • 16. Identification and Evaluation of Serum MicroRNA-29 Family for Glioma Screening.
    Wu J, Li L, Jiang C.
    Mol Neurobiol; 2015 Dec 02; 52(3):1540-1546. PubMed ID: 25367878
    [Abstract] [Full Text] [Related]

  • 17. Differentiation of primary central nervous system lymphoma from high-grade glioma and brain metastasis using arterial spin labeling and dynamic contrast-enhanced magnetic resonance imaging.
    Xi YB, Kang XW, Wang N, Liu TT, Zhu YQ, Cheng G, Wang K, Li C, Guo F, Yin H.
    Eur J Radiol; 2019 Mar 02; 112():59-64. PubMed ID: 30777220
    [Abstract] [Full Text] [Related]

  • 18. Intraoperative Flow Cytometry Enables the Differentiation of Primary Central Nervous System Lymphoma from Glioblastoma.
    Koriyama S, Nitta M, Shioyama T, Komori T, Maruyama T, Kawamata T, Muragaki Y.
    World Neurosurg; 2018 Apr 02; 112():e261-e268. PubMed ID: 29330078
    [Abstract] [Full Text] [Related]

  • 19. Methylated markers accurately distinguish primary central nervous system lymphomas (PCNSL) from other CNS tumors.
    Downs BM, Ding W, Cope LM, Umbricht CB, Li W, He H, Ke X, Holdhoff M, Bettegowda C, Tao W, Sukumar S.
    Clin Epigenetics; 2021 May 05; 13(1):104. PubMed ID: 33952317
    [Abstract] [Full Text] [Related]

  • 20. Primary central nervous system lymphoma and glioblastoma differentiation based on conventional magnetic resonance imaging by high-throughput SIFT features.
    Chen Y, Li Z, Wu G, Yu J, Wang Y, Lv X, Ju X, Chen Z.
    Int J Neurosci; 2018 Jul 05; 128(7):608-618. PubMed ID: 29183170
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.